Free Trial

Arcadia Biosciences Q2 2024 Earnings Report

Arcadia Biosciences logo
$3.98 -0.41 (-9.34%)
As of 02/21/2025 03:59 PM Eastern

Arcadia Biosciences EPS Results

Actual EPS
$0.78
Consensus EPS
$1.27
Beat/Miss
Missed by -$0.49
One Year Ago EPS
-$2.64

Arcadia Biosciences Revenue Results

Actual Revenue
$1.31 million
Expected Revenue
$0.95 million
Beat/Miss
Beat by +$360.00 thousand
YoY Revenue Growth
N/A

Arcadia Biosciences Announcement Details

Quarter
Q2 2024
Time
After Market Closes

Arcadia Biosciences Earnings Headlines

Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?
Arcadia Biosciences (RKDA) Gets a Buy from Lake Street
See More Arcadia Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email.

About Arcadia Biosciences

Arcadia Biosciences (NASDAQ:RKDA) produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

View Arcadia Biosciences Profile

More Earnings Resources from MarketBeat